MR-guided focused ultrasound for the treatment of adenomyosis: current insights

Abstract

Adenomyosis is a benign gynecological condition causing significant morbidity among women of reproductive age. The available treatments are currently limited in number and efficacy. While hysterectomy is curative, it is unacceptable to many women, particularly those wishing to conserve their fertility. Magnetic resonance-guided focused ultrasound surgery is a noninvasive treatment method that has been used to effectively treat uterine leiomyomata, but until recently has not been routinely used to treat adenomyosis. This review summarizes the current understanding of adenomyosis and high-intensity focused ultrasound, and the recent research into the safety and efficacy of this technique.

Correction to: A feasibility analysis of the ArcBlate MR‑guided high‑intensity focused ultrasound system for the ablation of uterine fibroids

“…However, one patient with adenomyosis in our study showed a lower shrinkage rate after 3 months than another study (our study vs. another study: 5.5% vs. 46.3%) [38]." should read as "No real-time monitoring in thermal damage in tissue was one of the limitations in ultrasonography-guided HIFU therapy [32], while it could be resolved under MR guidance. Besides, patients having pelvic endometriosis, adhesions locating between the uterus and bowel, or > 10-mm abdominal surgical scar are not recommended to receive HIFU therapy [33].…”

“…Keserci et al discovered that if the NPV achieved a ratio of at least 90%, the mean fibroid reduction ratio would be as high as 54 ± 13% [31]. A report of 80 patients with leiomyoma suggested that a larger NPV ratio would result in greater shrinkage and improved relief of symptoms [32]." should read as "A higher NPV ratio was found to be correlated with greater tumor volume shrinkage.…”